沙特阿拉伯儿童喘:对其患病率的元分析的见解
1Department of Pediatrics, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
Children (Basel, Switzerland)
|January 8, 2025
概括
喘影响了沙特阿拉伯近29%的儿童,男孩的发病率更高. 这次审查强调了需要采取公共卫生行动来解决儿童喘患病率的问题.
科学领域:
- 儿科肺病学 儿科肺病学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 儿童喘在全球范围内是一个重大的健康问题.
- 在沙特阿拉伯,关于儿科喘患病率的综合国家数据显著缺乏.
研究的目的:
- 进行系统性审查和元分析,以确定沙特阿拉伯儿童中喘的综合流行率.
- 确定导致喘患病率的因素,并为公共卫生战略提供信息.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和谷歌学者 (2015-2024) 进行了系统的文献搜索.
- 对包括9454名儿童在内的8项研究的元分析,使用随机效应模型汇集流行数据.
- 分析的重点是医生诊断的儿童喘.
主要成果:
- 沙特阿拉伯儿童喘的综合患病率估计为28.9%.
- 与女孩相比,男孩的喘患病率更高.
- 在研究中观察到高异质性 (I2 = 99%),城市化和环境因素被认为是贡献因素.
结论:
- 沙特阿拉伯儿童喘的高发病率需要紧急的公共卫生干预措施.
- 限制包括依赖自我报告的数据和潜在的出版偏见.
- 未来的研究应该采用标准化诊断方法,以更准确地估计患病率和有效的管理策略.
更多相关视频
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236


